Qube Research & Technologies (QRT)
ADPT icon

Qube Research & Technologies (QRT)’s Adaptive Biotechnologies ADPT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Sell
479,732
-159,645
-25% -$2.45M 0.01% 1271
2026
Q1 		$8.87M Sell
639,377
-274,783
-30% -$4.38M 0.01% 1350
2025
Q4 		$14.8M Sell
914,160
-38,069
-4% -$621K 0.02% 1087
2025
Q3 		$14.2M Buy
952,229
+587,461
+161% +$7.16M 0.01% 1093
2025
Q2 		$4.25M Buy
+364,768
New +$3.31M ﹤0.01% 1807
2024
Q1 		– Sell
-50,448
Closed -$247K – 4414
2023
Q4 		$247K Sell
50,448
-10,118
-17% -$46.2K ﹤0.01% 2688
2023
Q3 		$330K Buy
60,566
+19,315
+47% +$128K ﹤0.01% 2207
2023
Q2 		$277K Sell
41,251
-22,495
-35% -$167K ﹤0.01% 1678
2023
Q1 		$563K Buy
+63,746
New +$562K ﹤0.01% 1524
2022
Q4 		– Sell
-86,280
Closed -$614K – 2412
2022
Q3 		$614K Buy
86,280
+22,940
+36% +$216K ﹤0.01% 1392
2022
Q2 		$512K Buy
63,340
+9,669
+18% +$85K ﹤0.01% 1397
2022
Q1 		$745K Buy
+53,671
New +$844K 0.01% 1322
2021
Q2 		– Sell
-21,777
Closed -$877K – 2205
2021
Q1 		$877K Buy
+21,777
New +$1.18M 0.01% 902

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ADPT Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Adaptive Biotechnologies (ADPT) stake by 25% in Q2 2026, selling an estimated $2.45M and leaving 479,732 shares worth $10.3M. The position accounts for 0.01% of the portfolio, ranked #1271.

Qube Research & Technologies (QRT) first reported a position in ADPT in Q1 2021 and has held it in 13 quarters since. The position peaked at $14.8M in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Qube Research & Technologies (QRT) held 479,732 shares of Adaptive Biotechnologies worth $10.3M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 159,645 Adaptive Biotechnologies shares in Q2 2026, an estimated $2.45M.
  • Adaptive Biotechnologies made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1271 holding.
  • Qube Research & Technologies (QRT) first reported a position in Adaptive Biotechnologies in Q1 2021 and has held it in 13 quarters since.
  • Qube Research & Technologies (QRT)'s Adaptive Biotechnologies position peaked at $14.8M in Q4 2025.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.